e sometimes prescribed for purposes other than those listed in a patient information leaflet. Do not use ULORIC for a condition for which it was not prescribed. Do not give ULORIC to other people, even if they have the same symptoms that you have. It may harm them.
This patient information leaflet summarizes the most important information about ULORIC. If you would like more information about ULORIC talk with your healthcare provider. You can ask your healthcare provider or pharmacist for information about ULORIC that is written for health professionals. For more information go to www.uloric.com, or call 1-877-825-3327.
What are the ingredients in ULORIC?
Active Ingredient: febuxostat
Inactive ingredients include: lactose monohydrate, microcrystalline cellulose, hydroxypropyl cellulose, sodium croscarmellose, silicon dioxide, magnesium stearate, and Opadry II, green
Distributed by Takeda Pharmaceuticals America, Inc. Deerfield, IL 60015
U.S. Patent Nos. - 6,225,474; 7,361,676; 5,614,520.
ULORIC is a registered trademark of Teijin Pharma Limited and used under license by Takeda Pharmaceuticals America, Inc.
All other trademark names are the property of their respective owners
©2009 Takeda Pharmaceuticals America, Inc.
PI1114 R1February 2009
Repackaged by Rebel Distributors Corp
Thousand Oaks, CA 91320
PRINCIPAL DISPLAY PANEL - 80 mg 30 Tablet Bottle
30 Tablets Rx only
Uloric febuxostattablets
80 mg
Manufacturer
Rebel Distributors Corp
Active Ingredients
Source
U.S. National Library of Medicine
DailyMed
Last Updated: 2nd of March 2011
